Different genes related to alveolar stability have been associated with familial interstitial pneumonia (FIP). Here, we report a novel, rare SFTPA1 variant in a family with idiopathic interstitial pneumonia (IIP). We performed whole-exome sequencing on germline DNA samples from four members of one family; three of them showed signs of pulmonary fibrosis (idiopathic interstitial pneumonia) with autosomal-dominant inheritance. A heterozygous single nucleotide variant c.532 G > A in the SFTPA1 gene has been identified. This variant encodes the substitution p.(Val178Met), localized within the carbohydrate recognition domain of surfactant protein A and segregates with the genes causing idiopathic interstitial pneumonia. This rare variant has not been previously reported. We also analyzed the detected sequence variant in the protein structure in silico. The replacement of valine by the larger methionine inside the protein may cause a disruption in the protein structure. The c.532 G > A variant was further validated using Sanger sequencing of the amplicons, confirming the diagnosis in all symptomatic family members. Moreover, this variant was also found by Sanger sequencing in one other symptomatic family member and one young asymptomatic family member. The autosomal-dominant inheritance, the family history of IIP, and the evidence of a mutation occurring in part of the SFTPA1 gene all suggest a novel variant that causes FIP.

Central European Institute of Technology Masaryk University Brno Czech Republic

Department of Internal Medicine Hematology and Oncology University Hospital and Faculty of Medicine Brno Czech Republic

Department of Pneumology and Phtiseology University Hospital and Faculty of Medicine Brno Czech Republic

Zobrazit více v PubMed

Talbert JL, Schwartz DA, Steele MS. Familial interstitial pneumonia. Clin. Pulm. Med. 2014;21:120–127. PubMed PMC

American Thoracic Society/EuropeanRespiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS) and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Americant Thoracic Society; European Respiratory Society. Am. J. Respir. Crit. Care Med. 165, 277–304 (2002). PubMed

Spagnolo Paolo, Luppi Fabrizio, Cerri Stefania, Richeldi Luca. Genetic testing in diffuse parenchymal lung disease. Orphanet Journal of Rare Diseases. 2012;7(1):79. PubMed PMC

Steele MP, et al. Clinical and pathologic features of familial interstitial pneumonia. Am. J. Respir. Crit. Care. Med. 2005;172:1146–1152. PubMed PMC

Lee HL, et al. Familial idiopathic pulmonary fibrosis: clinical features and outcome. Chest. 2005;127:2034–2041. PubMed

Armanious MY, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 2007;356:1317–1326. PubMed

Tsakiri KD, et al. Adult – onset pulmonary fibrosis cause by mutations in telomerase. Proc. . Natl Acad. Sci. USA. 2007;104:7552–7557. PubMed PMC

Kropsi JA, et al. A novel dyskeratin (DKC1) mutation is associated with familial interstitial pneumonia. Chest. 2014;146:e1–e7. PubMed PMC

Alder JK, et al. Exome sequencing idetifies mutant TINF2 in family with pulmonary fibrosis. Chest. 2015;147:1361–1368. PubMed PMC

Cogan JD, et al. Rare variants in RTEL1 are associated with familial interstitial pneumonia. Am. J. Respir. Crit. Care. Med. 2015;191:646–655. PubMed PMC

Stuart BD, et al. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat. Genet. 2015;47:512–517. PubMed PMC

Moorsel CH, et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort. Am. J. Respir. Crit. Care. Med. 2010;182:1419–1425. PubMed

Campo Ilaria, Zorzetto Michele, Mariani Francesca, Kadija Zamir, Morbini Patrizia, Dore Roberto, Kaltenborn Eva, Frixel Sabrina, Zarbock Ralf, Liebisch Gerhard, Hegermann Jan, Wrede Christoph, Griese Matthias, Luisetti Maurizio. A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant. Respiratory Research. 2014;15(1):43. PubMed PMC

Wang Y, et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am. J. Hum. Genet. 2009;84:52–59. PubMed PMC

Nathan N, et al. Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer. Hum. Mol. Genet. 2016;25:1457–1467. PubMed

Lawson WE, Loyd JE, Degryse AL. Genetics in pulmonary fibrosis – familial cases provide clues to the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Med. Sci. 2011;341:439–443. PubMed PMC

Doan ML, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax. 2008;63:366–373. PubMed

Fingerlin TE, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat. Genet. 2013;45:613–620. PubMed PMC

Roy MG, et al. Muc5b is required for airway defence. Nature. 2014;505:412–416. PubMed PMC

Stenson PD, et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum. Genet. 2017;136:665–677. PubMed PMC

Lek M, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–291. PubMed PMC

Kircher M, et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 2014;46:310–315. PubMed PMC

Zamyatnin AA. Protein volume in solution. Prog. Biophys. Mol. Biol. 1972;24:107–123. PubMed

Hodgson U, Laitinen T, Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax. 2002;57:338–342. PubMed PMC

Musk AW, Zilko PJ, Manners P, Kay PH, Kamboh MI. Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes (Gm) Chest. 1986;89:206–210. PubMed

Marney A, Lane KB, Phillips JA, Riley DJ, Loyd JE. Idiopathic pulmonary fibrosis can be an autosomal dominant trait in some families. Chest. 2001;120((Suppl.1):56S. PubMed

Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax. 2000;5:143–146. PubMed PMC

Rosas IO, et al. Early interstitial lung disease in familial pulmonary fibrosis. Am. J. Respir. Crit. Care. Med. 2007;176:698–705. PubMed PMC

Kaur, A., Mathai, S. K. & Schwartz, D. A. Genetics in idiopathic pulmonary fibrosis. Pathogenesis, prognosis, and treatment. Front. Med.4, 10.3389/fmed.2017.00154 (2017). PubMed PMC

Nogee LM, et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 2001;344:573–579. PubMed

Tanjore H, et al. Alveolar epithelial cells undergo epithelial-to-mesenchymal transition in response to endoplasmic reticulum stress. J. Biol. Chem. 2011;286:30972–30980. PubMed PMC

Crossno PF, et al. Identification of early interstitial lung disease in an individual with genetic variations in ABCA3 and SFTPC. Chest. 2010;137:969–973. PubMed PMC

Kannegiesser C, et al. Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis. Eur. Respir. J. 2015;46:474–485. PubMed

Seibold MA, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 2011;364:1503–1512. PubMed PMC

Borrie R, et al. Management of suspected monogenic lung fibrosis in a specialised centre. Eur. Respir. Rev. 2017;26:160122. PubMed PMC

Whitsett JA. Genetic basis of familial interstitial lung disease: misfolding or function of surfactant protein C? Am. J. Respir. Crit. Care. Med. 2002;165:1201–1202. PubMed

Han S, Mallampalli RK. The role of surfactant in lung disease and host defense against pulmonary infections. Ann. Am. Thorac. Soc. 2015;12:765–774. PubMed PMC

Kolble K, Lu J, Mole SE, Kaluz S, Reid KB. Assignment of the human pulmonary surfactant protein D gene (SFTP4) to 10q22-q23 close to the surfactant protein A gene cluster. Genomics. 1993;17:294–298. PubMed

Lawson WE, et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008;249:L1119–L1126. PubMed

Whitsett JA, Wert SE, Weaver TE. Diseases of pulmonary surfactant homeostasis. Annu. Rev. Pathol. 2015;10:371–393. PubMed PMC

Selman M, et al. Surfactant protein A and B genetic variants predispose to indiopathic pulmonary fibrosis. Hum. Genet. 2003;113:542–550. PubMed

Raghu G, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-gased guidelines for diagnosis and management. Am. J. Respir. Crit. Care. Med. 2011;183:788–824. PubMed PMC

Raghu G, et al. An Official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. an update of the 2011 clinical practice guideline. Am. J. Respir. Crit. Care. Med. 2015;192:e3–e19. PubMed

Travis WD, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care. Med. 2013;188:733–748. PubMed PMC

Kropski JA, et al. Genetic evaluation and testing of patients and families with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care. Med. 2017;195:1423–1428. PubMed PMC